Physician

Thomas Alan Parfenchuck, MD

According to 2025 Medicare claims, Thomas Parfenchuck, MD (NPI: 1053346973) practices orthopedic surgery in the Augusta-Richmond County, GA-SC market, with the plurality of this provider's patient population coming from Aiken, SC. This provider's primary affiliated billing organization is AUGUSTA ORTHOPEDIC & SPORTS MEDICINE SPECIALISTS PC (NPI: 1457389504; TIN: 581327528) and primary practice location at 30901-2612. Parfenchuck is affiliated with the Southeastern Health Partners (ACO ID: A3325), participating under the MSSP model.

Parfenchuck's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 460 traditional Medicare patients, billed 2,205 HCPCS/CPT codes, and received $272,651 in Medicare payments. The top billing code was 22853 (Insertion of cage or mesh device to spine bone and disc space during spine fusion). Part D data shows 2,845 prescription claims across 663 beneficiaries totaling $29,971 in drug costs, led by Celecoxib (Celecoxib). DME data shows 26 claims. Open Payments data shows 3 records totaling $133. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $447,443 to $272,651. Concurrently, Part D prescription costs have changed little. For DME billing, reported payments rose steadily, from $1,885 to $108,581.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	675	3,637	$447,443
2016	686	3,543	$420,439
2017	634	3,643	$432,499
2018	649	3,375	$368,754
2019	699	3,557	$411,193
2020	606	2,964	$338,492
2021	601	2,705	$327,093
2022	551	2,754	$351,672
2023	458	1,882	$277,007
2024	460	2,205	$272,651

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	376	1,385	$35,448
2016	383	1,378	$36,154
2017	379	1,280	$36,799
2018	363	1,092	$30,946
2019	438	1,722	$32,842
2020	452	1,901	$35,511
2021	502	1,841	$40,746
2022	465	1,833	$37,680
2023	521	2,257	$32,738
2024	663	2,845	$29,971

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	56	56	$135,005
2020	53	53	$135,397
2021	17	17	$58,437
2022	38	38	$102,002
2023	21	21	$85,187
2024	26	26	$108,212

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
22853	Insertion of cage or mesh device to spine bone and disc space during spine fusion	64	134	$183
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	267	372	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	68	69	$64
72100	X-ray of lower and sacral spine, 2-3 views	170	231	$27
72040	X-ray of upper spine, 2-3 views	66	80	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Celecoxib	Celecoxib	354	14,035	$4,442
Gabapentin	Gabapentin	298	13,046	$4,183
Pregabalin	Pregabalin	244	8,580	$4,001
Diclofenac Sodium	Diclofenac Sodium	234	7,915	$2,787
Methocarbamol	Methocarbamol	215	6,726	$2,472

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0748	Osteogenesis stimulator, electrical, non-invasive, spinal applications	N	26	26	$108,212

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$133	Providence Medical Technology, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Thomas Alan Parfenchuck, MD?

Tedicare shows public-source Medicare data for Thomas Alan Parfenchuck, MD (NPI 1053346973), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas Alan Parfenchuck, MD have ACO affiliation data?

Thomas Alan Parfenchuck, MD is shown with ACO affiliation data for Southeastern Health Partners (MSSP, ACO ID A3325).

What billing organization is linked to Thomas Alan Parfenchuck, MD?

Thomas Alan Parfenchuck, MD is linked to AUGUSTA ORTHOPEDIC & SPORTS MEDICINE SPECIALISTS PC (billing NPI 1457389504) in the available physician profile data.

Does Thomas Alan Parfenchuck, MD have Open Payments data?

Thomas Alan Parfenchuck, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.